The global cannula market size was estimated at USD 112.4 million in 2017 and it is anticipated to expand at a CAGR of 7.5% during the forecast period. The surge in awareness about minimally invasive surgeries, increasing infant mortality rate, improving healthcare infrastructure in emerging economies, and rising number of hospitals and clinics are anticipated to drive the global market.
Growing consumer awareness and support initiatives being undertaken by governments around the world to provide primary healthcare services at affordable rates are also anticipated to propel the market. In addition, a rise in the number of medical ailments arising due to a sedentary lifestyle is anticipated to have a positive impact on product sales.
Increasing demand for minimally invasive surgery (MIS) is expected to boost demand for cannulas over the forecast period. Advanced cannulas with improved features enable shorter procedure duration and faster patient recovery. The growing availability of such devices is also likely to fuel the market.
Other factors that will benefit market growth include increasing pool of patients undergoing surgical procedures, advancement in healthcare infrastructure, increasing number of surgeries in the elderly population, and growing prevalence of lifestyle-related diseases such as obesity and diabetes.
On the basis of product, the market can be segmented into cardiac (arterial, venous, cardioplegia, and femoral), dermatology, nasal, and others. The cardiac segment held a lucrative market share in terms of revenue in 2017. This may be attributed to the high prevalence rate of cardiovascular diseases.
The dermatology segment is anticipated to gain significant market share over the forecast period, exhibiting the fastest CAGR through 2026. The segment held over 20.0% of the total market in 2017. This growth can be attributed to the increasing use of microcannula in order to avoid complications during and after procedures. Additionally, a rise in cosmetic surgery is likely to boost this segment. In the U.S., nearly 15.7 million cosmetic minimally invasive surgeries were performed in 2017 alone. This increasing penetration of MIS will benefit segment growth over the forecast period.
Based on type, the market is segmented into neonatal, straight, winged, wing with port, and winged with stop cork. Straight cannulas held a lucrative market share in 2017. This can be attributed to its simple and straight design. Its extra-sharp needle makes it easier to insert.
Neonatal cannulas are anticipated to grow at a steady pace over the forecast period due to the increasing prevalence of respiratory problems among newborns. Its soft and flexible nature makes it suitable for neonatal use in high flow oxygen therapy.
On the basis of material, the market is segmented into plastic, metal, and silicone. The plastic segment held the dominant share of over 50.0% in 2017. Its extensive usage in general surgeries, in both in-patient and out-patient procedures, is the key factor driving this segment.
The silicone segment is expected to grow at the fastest rate in the global cannula market. This is due to their high usage rate in oxygen therapies, to ensure a continuous supply of oxygen to patients during surgery and people suffering from respiratory disorders. In addition, silicon cannulas are flexible and soft, making them a preferred choice for application among doctors as well as patients.
The market is fragmented based on gauge size into 14G, 16G, 18G, 20G, 22G, 24G, and 26G. Different sized cannulas are represented by specific colors. For instance, orange and green represent the sizes 14G and 18G, respectively. The 18G sized segment accounted for the largest market share in 2017. This is the most commonly used product in hospitals for adults and adolescents.
The 22G sized segment is anticipated to witness the fastest growth throughout the forecast period, owing to its small gauge size, which allows the faster flow of fluid in children and in patients with complicated veins.
Cannulas are used in hospitals, ambulatory surgical centers (ASC), blood banks, laboratories, pathology labs, and other healthcare settings. The hospital segment held the dominant share of 53.5% in 2017. This market share is attributed to an increase in the hospitalization rate. In hospitals, cannulas are used in general surgery, orthopedic surgery, cardiovascular surgery, dermatology, neurology, gynecology, oxygen therapy, and many more.
Ambulatory surgical centers are expected to gain significant market share over the forecast period, which can be attributed to increasing demand for modern healthcare facilities that do not require an overnight stay.
North America led the global market in 2017 and is anticipated to witness the same trend over the forecast period. This can be attributed to the availability of advanced healthcare infrastructure and greater awareness about minimally invasive surgeries among patients and physicians.
Asia Pacific is anticipated to witness the fastest growth over the forecast period. This is owing to the presence of a massive patient pool, coupled with a high proportion of geriatrics suffering from chronic diseases such as diabetes and cardiovascular diseases. Moreover, favorable government policies to transform healthcare practices in respective countries, particularly in rural belts, will boost the Asia Pacific market.
Some of the key companies operating in this industry are Medtronic, Becton Dickinson (BD), Edward Lifesciences, LivaNova, Smiths Medical, and Boston Scientific Corporation. Various strategies such as mergers, acquisitions, collaborations, and new product launches are being adopted by these players to maintain their market share and gain a stronger foothold.
In February 2018, LivaNova introduced a new line of arterial cannula called PureFlex- curved and straight tip. Designed to meet varied clinical needs, it is available in a variety of configurations, including a new tip design that allows for easy insertion.
Base year for estimation
Actual estimates/Historical data
2014 - 2016
2018 - 2026
Revenue in USD Million & CAGR from 2018 to 2026
North America, Europe, Asia Pacific, Latin America, MEA
U.S., Canada, U.K., Germany, Japan, China, Brazil, Mexico, South Africa, Saudi Arabia
Revenue forecast, volumes sold, company share, competitive landscape, growth factors and trends
15% free customization scope (equivalent to 5 analyst working days)
If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2026. For the purpose of this study, Grand View Research has segmented the global cannula market report on the basis of product, type, material, size, end use, and region:
Product Outlook (Revenue, USD Million, 2014 - 2026)
Type Outlook (Revenue, USD Million, 2014 - 2026)
Wing with port
Winged with stop cork
Material Outlook (Revenue, USD Million, 2014 - 2026)
Size Outlook (Revenue, USD Million, 2014 - 2026)
End-use Outlook (Revenue, USD Million, 2014 - 2026)
Ambulatory Surgical Centers
Regional Outlook (Revenue, USD Million, 2014 - 2026)
Middle East & Africa
b. The global cannula market size was estimated at USD 125.8 million in 2019 and is expected to reach USD 134.1 million in 2020.
b. The global cannula market is expected to grow at a compound annual growth rate of 7.5% from 2018 to 2026 to reach USD 212.0 million by 2026.
b. North America dominated the cannula market with a share of 40.7% in 2019. This is attributable to the availability of advanced healthcare infrastructure and greater awareness about minimally invasive surgeries among patients and physicians.
b. Some key players operating in the cannula market include Medtronic, Becton Dickinson (BD), Edward Lifesciences, LivaNova, Smiths Medical, and Boston Scientific Corporation.
b. Key factors that are driving the market growth include surge in awareness about minimally invasive surgeries, increasing infant mortality rate, improving healthcare infrastructure in emerging economies, and rising number of hospitals and clinics.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
With Covid-19 infections rising globally, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies in order to prevent the spread of this pandemic and provide optimum care to the infected also widens. In addition, till a pharmacological treatment is developed, ventilators act as a vital treatment preference for the COVID-19 patients, who may require critical care. Moreover, there is an urgent need for a rapid acceleration in the manufacturing process for a wide range of test-kits (antibody tests, self-administered, and others). The report will account for Covid19 as a key market contributor.